These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31641010)

  • 1. Beta-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non-Small Cell Lung Cancer.
    Udumyan R; Montgomery S; Fang F; Valdimarsdottir U; Hardardottir H; Ekbom A; Smedby KE; Fall K
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):119-126. PubMed ID: 31641010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients.
    Udumyan R; Montgomery S; Duberg AS; Fang F; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
    Scand J Gastroenterol; 2020 May; 55(5):597-605. PubMed ID: 32412855
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of beta-blockers on survival of lung cancer patients: a systematic review and meta-analysis.
    Coelho M; Squizzato A; Cassina N; Marino F; Ribeiro LV; Cosentino M
    Eur J Cancer Prev; 2020 Jul; 29(4):306-314. PubMed ID: 31609808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
    Wang HM; Liao ZX; Komaki R; Welsh JW; O'Reilly MS; Chang JY; Zhuang Y; Levy LB; Lu C; Gomez DR
    Ann Oncol; 2013 May; 24(5):1312-9. PubMed ID: 23300016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study.
    Ahl R; Matthiessen P; Sjölin G; Cao Y; Wallin G; Ljungqvist O; Mohseni S
    BMJ Open; 2020 Jul; 10(7):e036164. PubMed ID: 32641361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.
    Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
    Cancer Res; 2017 Jul; 77(13):3700-3707. PubMed ID: 28473530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study.
    Udumyan R; Botteri E; Jerlstrom T; Montgomery S; Smedby KE; Fall K
    Acta Oncol; 2022 Aug; 61(8):922-930. PubMed ID: 35881046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does beta-blocker therapy improve the survival of patients with metastatic non-small cell lung cancer?
    Aydiner A; Ciftci R; Karabulut S; Kilic L
    Asian Pac J Cancer Prev; 2013; 14(10):6109-14. PubMed ID: 24289634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
    Weberpals J; Jansen L; Haefeli WE; Hoffmeister M; Wolkewitz M; Herk-Sukel MPPV; Vissers PAJ; Brenner H
    Sci Rep; 2017 Jun; 7(1):2911. PubMed ID: 28588274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative beta-blocker use and survival in lung cancer patients.
    Cata JP; Villarreal J; Keerty D; Thakar DR; Liu DD; Sood AK; Gottumukkala V
    J Clin Anesth; 2014 Mar; 26(2):106-17. PubMed ID: 24480297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
    Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
    Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
    Bugge AS; Lund MB; Valberg M; Brustugun OT; Solberg S; Kongerud J
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):221-227. PubMed ID: 28950311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.
    Löfling L; Karimi A; Sandin F; Bahmanyar S; Kieler H; Lambe M; Lamberg K; Wagenius G
    Acta Oncol; 2019 Nov; 58(11):1618-1627. PubMed ID: 31373239
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.
    Parker WP; Lohse CM; Zaid HB; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Urol Oncol; 2017 Jan; 35(1):36.e1-36.e6. PubMed ID: 27687543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.
    Risteski M; Crvenkova S; Atanasov Z; Isjanovska R
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):49-61. PubMed ID: 24566015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Severe Complications, Beta-Blocker Therapy and Long-Term Survival Following Emergency Surgery for Colon Cancer.
    Ahl R; Matthiessen P; Cao Y; Sjolin G; Ljungqvist O; Mohseni S
    World J Surg; 2019 Oct; 43(10):2527-2535. PubMed ID: 31214833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.
    Cardwell CR; Coleman HG; Murray LJ; Entschladen F; Powe DG
    Int J Epidemiol; 2013 Dec; 42(6):1852-61. PubMed ID: 24536096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer.
    Reda S; Ahl R; Szabo E; Stenberg E; Forssten MP; Sjolin G; Cao Y; Mohseni S
    BMC Surg; 2020 Dec; 20(1):333. PubMed ID: 33353542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.